LAZR Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||
net income | -148,401,000 | -134,338,000 | -141,756,000 | -146,774,000 | -144,817,000 | -117,550,000 | -95,239,000 | -88,333,000 | -73,893,000 | -51,340,000 | -36,830,000 | -75,923,000 | -120,922 | 768,880 | ||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||
depreciation and amortization | 7,156,000 | 11,932,000 | 4,549,000 | 2,987,000 | 2,192,000 | 1,830,000 | 1,739,000 | 805,000 | 1,922,000 | 908,000 | 675,000 | 657,000 | ||||||||
amortization of operating lease right-of-use assets | 1,892,000 | 1,792,000 | 1,693,000 | 1,610,000 | 1,706,000 | |||||||||||||||
amortization of premium (discount) on marketable securities | -1,977,000 | -2,341,000 | -868,000 | -743,000 | 262,000 | |||||||||||||||
loss on marketable securities | -180,000 | 5,915,000 | -1,174,000 | 3,033,000 | ||||||||||||||||
losses and impairments on non-marketable securities and certain other assets | ||||||||||||||||||||
change in fair value of warrants | -2,577,000 | 1,231,000 | -11,733,000 | 3,857,000 | -17,072,000 | -6,928,000 | 46,649,000 | |||||||||||||
vendor stock-in-lieu of cash program | 19,342,000 | 10,373,000 | 15,430,000 | 5,684,000 | 8,972,000 | 12,571,000 | 12,068,000 | 7,848,000 | ||||||||||||
amortization of debt discount and issuance costs | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | ||||||||||||
inventory write-offs and write-downs | 2,204,000 | 3,911,000 | 7,981,000 | 5,451,000 | ||||||||||||||||
write-off or loss on sale or disposal of property and equipment | ||||||||||||||||||||
share-based compensation | 47,101,000 | 44,882,000 | 59,195,000 | 55,954,000 | 44,531,000 | 52,551,000 | 38,625,000 | 26,698,000 | 27,797,000 | 33,520,000 | 14,530,000 | 1,837,000 | ||||||||
impairment of goodwill and intangible assets | ||||||||||||||||||||
expense related to volvo warrants | ||||||||||||||||||||
product warranty | ||||||||||||||||||||
deferred taxes | 2,000 | |||||||||||||||||||
other | -578,000 | 371,000 | -63,000 | 575,000 | ||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||
accounts receivable | 4,778,000 | -2,094,000 | 4,242,000 | -9,877,000 | -1,313,000 | -581,000 | -2,719,000 | 9,757,000 | -11,981,000 | 2,221,000 | -301,000 | 3,828,000 | ||||||||
inventories | 2,298,000 | -291,000 | -13,380,000 | -11,578,000 | -3,829,000 | -3,834,000 | -2,046,000 | -768,000 | -4,093,000 | -4,018,000 | -2,198,000 | -442,000 | ||||||||
prepaid expenses and other current assets | 783,000 | -3,000,000 | 3,926,000 | 9,932,000 | -1,872,000 | -2,268,000 | 883,000 | -3,300,000 | -7,369,000 | -8,502,000 | -2,672,000 | -5,797,000 | ||||||||
other non-current assets | 3,635,000 | 1,829,000 | -1,131,000 | -4,156,000 | -1,918,000 | -839,000 | -690,000 | 158,000 | 82,000 | 1,402,000 | -172,000 | -1,318,000 | ||||||||
accounts payable | -361,000 | 257,000 | -7,430,000 | 11,191,000 | -3,078,000 | 987,000 | 1,409,000 | 5,983,000 | 508,000 | 2,476,000 | -912,000 | 1,766,000 | ||||||||
accrued and other current liabilities | -5,221,000 | 3,452,000 | -724,000 | 11,651,000 | 12,052,000 | 4,610,000 | -94,000 | 1,200,000 | -2,332,000 | 3,258,000 | 3,465,000 | -813,000 | ||||||||
other non-current liabilities | -1,101,000 | -588,000 | -7,143,000 | -1,488,000 | 1,536,000 | -2,640,000 | -588,000 | -343,000 | -1,922,000 | -2,436,000 | -939,000 | -720,000 | ||||||||
net cash from operating activities | -52,778,000 | -56,543,000 | -73,309,000 | -64,674,000 | -74,673,000 | -48,361,000 | -52,361,000 | -32,837,000 | -54,165,000 | -36,073,000 | -30,169,000 | -28,014,000 | 875,556 | |||||||
cash flows from investing activities: | ||||||||||||||||||||
acquisition of freedom photonics llc | 0 | |||||||||||||||||||
acquisition of certain assets from solfice research, inc. | 0 | |||||||||||||||||||
cash received from acquisition of optogration, inc. | 0 | |||||||||||||||||||
acquisition of seagate’s lidar business | 0 | 0 | 0 | -12,608,000 | ||||||||||||||||
purchases of marketable securities | -32,329,000 | -98,046,000 | -89,495,000 | -81,623,000 | -40,692,000 | -93,466,000 | -76,753,000 | -193,687,000 | -186,754,000 | -153,890,000 | -150,044,000 | -226,245,000 | ||||||||
proceeds from maturities of marketable securities | 129,450,000 | 113,065,000 | 129,426,000 | 148,345,000 | 113,299,000 | 107,015,000 | 55,599,000 | 91,454,000 | 59,950,000 | 137,288,000 | 100,344,000 | 69,275,000 | ||||||||
proceeds from sales/redemptions of marketable securities | 787,000 | 12,417,000 | 18,987,000 | 20,165,000 | ||||||||||||||||
purchases of property and equipment | -786,000 | -4,298,000 | -5,151,000 | -11,680,000 | -4,337,000 | -3,786,000 | -2,487,000 | -5,004,000 | -2,278,000 | -1,445,000 | -1,821,000 | -889,000 | ||||||||
disposal of property and equipment | ||||||||||||||||||||
advances for capital projects and equipment | -441,000 | -336,000 | ||||||||||||||||||
net cash from investing activities | 97,122,000 | 23,138,000 | 53,767,000 | 62,599,000 | 87,066,000 | 27,916,000 | 7,399,000 | -94,395,000 | -50,612,000 | 28,867,000 | -44,089,000 | -128,354,000 | -1,263,655 | |||||||
cash flows from financing activities: | ||||||||||||||||||||
net proceeds from issuance of class a common stock under the equity financing program | 11,479,000 | 9,107,000 | 6,939,000 | 22,665,000 | ||||||||||||||||
proceeds from issuance of class a common stock to a tpk group company | ||||||||||||||||||||
proceeds from a financing transaction | ||||||||||||||||||||
proceeds from issuance of convertible senior notes, net of debt discounts of 15,625 | ||||||||||||||||||||
purchases of capped call options | ||||||||||||||||||||
repayment of debt | 47,000 | -16,000 | -68,000 | -75,000 | ||||||||||||||||
principal payments on finance leases | -76,000 | -67,000 | ||||||||||||||||||
proceeds from exercise of warrants | 0 | 0 | 0 | 153,927,000 | ||||||||||||||||
proceeds from exercise of stock options | 501,000 | 990,000 | 534,000 | 1,036,000 | 1,095,000 | 1,100,000 | 699,000 | 1,092,000 | 1,121,000 | 1,926,000 | 2,491,000 | 321,000 | ||||||||
proceeds from sale of class a common stock under espp | 1,235,000 | 0 | ||||||||||||||||||
payments of employee taxes related to stock-based awards | -1,565,000 | 0 | 0 | -572,000 | -957,000 | -1,049,000 | ||||||||||||||
repurchases of common stock and redemption of warrants | ||||||||||||||||||||
other financing activities | 215,000 | |||||||||||||||||||
net cash from financing activities | 18,092,000 | 20,097,000 | 18,879,000 | 23,129,000 | 1,409,000 | 51,000 | -37,467,000 | -43,344,000 | 305,431,000 | 1,840,000 | 2,217,000 | 154,104,000 | ||||||||
net increase in cash, cash equivalents and restricted cash | 62,436,000 | -13,308,000 | -663,000 | 21,054,000 | 200,654,000 | |||||||||||||||
beginning cash, cash equivalents and restricted cash | 0 | 0 | 0 | 71,105,000 | 0 | 0 | 0 | 330,702,000 | 0 | 0 | ||||||||||
ending cash, cash equivalents and restricted cash | 62,436,000 | -13,308,000 | -663,000 | 92,159,000 | 13,802,000 | -20,394,000 | -82,429,000 | 160,126,000 | 200,654,000 | -5,366,000 | ||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||||||
cash paid for interest | 3,907,000 | 0 | 3,906,000 | 0 | 16,000 | 18,000 | 19,000 | |||||||||||||
supplemental disclosures of noncash investing and financing activities: | ||||||||||||||||||||
issuance of class a common stock upon exercise of warrants | 0 | 0 | 314,000 | 18,689,000 | 0 | 0 | 338,293,000 | |||||||||||||
issuance of class a common stock for investment in plus | ||||||||||||||||||||
issuance of class a common stock for investment in robotic research opco, llc | ||||||||||||||||||||
issuance of class a common stock to acquire optogration, inc. | ||||||||||||||||||||
operating lease right-of-use assets obtained in exchange for lease obligations upon adoption of asc 842 | 0 | 0 | 10,849,000 | |||||||||||||||||
operating lease right-of-use assets obtained in exchange for lease obligations | 25,112,000 | 387,000 | 1,737,000 | 1,211,000 | 0 | 6,756,000 | 4,247,000 | 5,746,000 | 0 | 0 | 2,876,000 | |||||||||
purchases of property and equipment recorded in accounts payable and accrued liabilities | -1,368,000 | -3,245,000 | -2,539,000 | 7,978,000 | 2,207,000 | -967,000 | 680,000 | 1,950,000 | 321,000 | -282,000 | 504,000 | |||||||||
amounts payable for shares repurchased | ||||||||||||||||||||
vendor stock-in-lieu of cash program—advances for capital projects and equipment | 1,140,000 | 3,166,000 | 1,725,000 | 2,520,000 | 7,378,000 | 10,731,000 | ||||||||||||||
investment in ecarx holdings, inc. | ||||||||||||||||||||
change in fair value of private warrants | -2,373,000 | -26,000 | 1,054,000 | |||||||||||||||||
loss on investment in non-marketable securities | ||||||||||||||||||||
product warranty and other | 1,189,000 | 2,498,000 | 586,000 | -794,000 | 64,000 | 107,000 | ||||||||||||||
acquisition of certain assets from solfice | ||||||||||||||||||||
proceeds from issuance of class a common stock to a wholly owned subsidiary of tpk | 10,000,000 | |||||||||||||||||||
repurchase of common stock | ||||||||||||||||||||
investment in plus | ||||||||||||||||||||
amortization of premium on marketable securities | 177,000 | 192,000 | 475,000 | 444,000 | ||||||||||||||||
loss on sale or disposal of property and equipment | ||||||||||||||||||||
loss on extinguishment of debt | ||||||||||||||||||||
impairment of investments and certain other assets | ||||||||||||||||||||
warranty related to sensors | 299,000 | |||||||||||||||||||
proceeds from refundable security deposits | ||||||||||||||||||||
cash received from gores on recapitalization | ||||||||||||||||||||
transaction costs related to merger with gores | ||||||||||||||||||||
proceeds from issuance of series x convertible preferred stock | ||||||||||||||||||||
issuance cost paid for series x convertible preferred stock | ||||||||||||||||||||
proceeds from the issuance of debt | ||||||||||||||||||||
debt prepayment charges | ||||||||||||||||||||
debt issuance costs | ||||||||||||||||||||
conversion of series a, series x and founders’ convertible preferred stock into class a and class b common stock | ||||||||||||||||||||
assets acquired under finance leases | ||||||||||||||||||||
impairment of inventories | 3,972,000 | 3,422,000 | 1,356,000 | 1,317,000 | 148,000 | 1,196,000 | 257,000 | |||||||||||||
proceeds from sales of marketable securities | 18,489,000 | 37,473,000 | 12,842,000 | 46,556,000 | 7,432,000 | 29,505,000 | ||||||||||||||
repurchase of common stock and redemption of warrants | 0 | -36,958,000 | -43,920,000 | 0 | -2,000 | |||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -20,394,000 | -82,429,000 | -170,576,000 | |||||||||||||||||
noncash lease expense related to operating lease right-of-use assets | 1,254,000 | 885,000 | ||||||||||||||||||
acquisition of freedom photonics | ||||||||||||||||||||
acquisition of solfice assets | ||||||||||||||||||||
receivable from stock option exercises | ||||||||||||||||||||
payments of employee taxes related to vested restricted stock units | -516,000 | |||||||||||||||||||
deferred financing costs recorded in accrued liabilities | 223,000 | |||||||||||||||||||
noncash lease expense relating to operating lease right-of-use assets | ||||||||||||||||||||
change in fair value of warrants and safe liabilities | ||||||||||||||||||||
settlement of safe notes | ||||||||||||||||||||
proceeds from issuance of series a convertible preferred stock | ||||||||||||||||||||
proceeds from issuance of safe notes | ||||||||||||||||||||
proceeds from issuance of restricted common stock | ||||||||||||||||||||
share-based compensation—vendor payments | ||||||||||||||||||||
merger related expense recorded in accounts payable and accrued liabilities | ||||||||||||||||||||
issuance cost for series x preferred stock recorded in accounts payable | ||||||||||||||||||||
noncash lease expense related to operating right-of-use assets | 858,000 | 890,000 | ||||||||||||||||||
unrealized loss on marketable securities | -218,000 | 278,000 | ||||||||||||||||||
cash received from gores on settlement of recapitalization of escrow | ||||||||||||||||||||
net decrease in cash and cash equivalents, and restricted cash and cash equivalents | -2,264,000 | |||||||||||||||||||
beginning cash and cash equivalents, and restricted cash and cash equivalents | 209,719,000 | |||||||||||||||||||
ending cash and cash equivalents, and restricted cash and cash equivalents | 207,455,000 | |||||||||||||||||||
loss on disposal of property and equipment | ||||||||||||||||||||
principal payments on capital leases | ||||||||||||||||||||
net increase in cash and cash equivalents, and restricted cash and cash equivalents | ||||||||||||||||||||
conversion of bridge note into series a convertible preferred stock | ||||||||||||||||||||
conversion of safe notes into common stock | ||||||||||||||||||||
conversion of safe notes into series a convertible preferred stock | ||||||||||||||||||||
assets acquired on capital leases | ||||||||||||||||||||
net income/ | ||||||||||||||||||||
supplemental disclosure of cash and non-cash financing activities: | ||||||||||||||||||||
deferred underwriting compensation | ||||||||||||||||||||
basic and diluted net income/(loss) per share: | ||||||||||||||||||||
numerator: | ||||||||||||||||||||
denominator: | ||||||||||||||||||||
weighted-average shares outstanding | 0 | 0 | 40,000,000 | 0 | 1,555,599,999,340,312 | 2,444,400,010,659,688 | ||||||||||||||
basic and diluted net income/(loss) per share | -0.08 | -0.02 | 0.02 | -0.01 | 0.01 | 0.04 | ||||||||||||||
accrued expenses, formation, and offering costs | ||||||||||||||||||||
changes in prepaid assets | ||||||||||||||||||||
changes in current income tax | ||||||||||||||||||||
proceeds from notes and advances payable - related party | ||||||||||||||||||||
proceeds from sale of class f common stock to sponsor | ||||||||||||||||||||
payment of underwriter's discounts and commissions | ||||||||||||||||||||
supplemental disclosure of non-cash financing activities: | ||||||||||||||||||||
1. |